Single-chain variable fragment: Difference between revisions

Content deleted Content added
Undid good faith edit 913179383 by 198.176.191.201 (talk) see WP:®
Jdevola (talk | contribs)
Examples: accuracy
Line 18:
 
==Examples==
* [[Pexelizumab]], a scFv binding to [[Complement component 5|component 5]] of the [[complement system]] and useddesigned to reduce side effects of [[cardiac surgery]]<ref>{{cite journal|pmid=15331798|year=2004|last1=Mathew|first1=JP|last2=Shernan|first2=SK|last3=White|first3=WD|last4=Fitch|first4=JC|last5=Chen|first5=JC|last6=Bell|first6=L|last7=Newman|first7=MF|title=Preliminary report of the effects of complement suppression with pexelizumab on neurocognitive decline after coronary artery bypass graft surgery|volume=35|issue=10|pages=2335–9|doi=10.1161/01.STR.0000141938.00524.83|journal=Stroke: A Journal of Cerebral Circulation}}</ref>
* C6.5, a diabody targeting [[HER2/neu]]<ref name="Adams" /> found in some [[breast cancer]]s
* [[Brolucizumab]], a scFV binding to VEGF-A and used to treat wet age-related macular degeneration